191 related articles for article (PubMed ID: 8912561)
1. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
2. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
7. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
8. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure.
Snellman E; Rantanen T; Sundell J
Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):207-10. PubMed ID: 11068859
[TBL] [Abstract][Full Text] [Related]
9. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
11. Shower PUVA: a novel variant of photochemotherapy. Distribution of photosensitivity and accumulation of trioxsalen in the skin.
Sánchez Ruderisch H; Aryee-Boi J; Schwarz C; Radenhausen M; Tebbe B
Skin Pharmacol Physiol; 2004; 17(3):129-32. PubMed ID: 15087592
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis, its treatment, and cancer in a cohort of Finnish patients.
Hannuksela-Svahn A; Pukkala E; Läärä E; Poikolainen K; Karvonen J
J Invest Dermatol; 2000 Mar; 114(3):587-90. PubMed ID: 10692122
[TBL] [Abstract][Full Text] [Related]
13. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
Väätäinen N; Hollmen A; Fräki JE
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
[TBL] [Abstract][Full Text] [Related]
14. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
15. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets.
Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG
Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682
[TBL] [Abstract][Full Text] [Related]
16. Time course of skin photosensitivity following trimethylpsoralen bath PUVA.
Man I; Wainwright NJ; Gibbs NK; Ferguson J
Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):211-5. PubMed ID: 11068860
[TBL] [Abstract][Full Text] [Related]
17. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen.
Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443
[TBL] [Abstract][Full Text] [Related]
18. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
19. Treatment of psoriasis with polyethylene sheet bath PUVA.
Streit V; Wiedow O; Christophers E
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
[TBL] [Abstract][Full Text] [Related]
20. Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results.
Salo OP; Lassus A; Taskinen J
Acta Derm Venereol; 1981; 61(6):551-4. PubMed ID: 6177169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]